A new anti-malaria strategy involving a vaccination containing weakened malaria parasites is one step closer, following new research published this week.
The most recent study involving the new vaccine was a follow-up animal study, undertaken following a human clinical trial which did not yield the positive results the researchers had hoped for, with just two out of 40 study participants showing signs of protection against the malaria infection after receiving the vaccination. A previous study of 80 volunteers had proved that the vaccine itself was safe. Researchers believe that the way in which the vaccine is delivered may have an effect on its efficacy, which....
Human trials could occur in as little as six months for a new malaria vaccine that has been invent.. More..
A report into malaria funding has shown a four-fold rise in funds over a sixteen year period, from.. More..
Scientists and geneticists have recently published work that reveals a longstanding genetic strugg.. More..